China has been growing economically by leaps and bounds in recent years, and is now second only to the US in terms of GDP (at least according to this data), followed by Japan, Germany and the UK. Given a normal expected path of growth, it would be expected that growth in generation of IP would follow. This does appear to be the case. A recent article even claims that China could beat the US and Japan within the next two years, based on the number of international patent applications filed, suggesting that the US may be losing the "innovation race" (whatever that means).
Two large Chinese companies, Huawei and ZTE, dominated in 2016 in terms of the number of PCT applications filed, according to a recent report from WIPO, with US company Qualcomm in third place. What is not said, though, is how this translates into applications being pursued beyond the international phase and resulting in granted patents. For this, we have to go beyond the headline figures and start looking into the slightly murky world of patent statistics.
Looking first at the number of international applications filed, it is true that those originating from China have been growing at a very high rate over the past few years. This can be seen from the chart below, which shows the number of PCT/CN and PCT/US applications by publication year (data sourced from here). At the current rate of increase, and assuming the US stays fairly constant, China will probably catch up to the US within the next few years.
This is, however, not the whole story. PCT applications, as with any other types of patent application, are not granted patents. Pretty much anything can be filed as a patent application and it would still count, regardless of its merits. What actually matters is whether these patent applications are proceeded with into the national or regional phase (which costs more money, and therefore has to be justifiable in light of the preliminary examination PCT applications are subject to), and then whether they end up being granted. The number of applications that proceed into the European regional phase is, unfortunately, not something that is easy to assess. The EPO seems to have data on this only for the past year, counting 7150 applications originating from China, but nothing from previous years, making a comparison over time impossible without a lot more digging.
A better indication is the number of applications granted. There is, of course, a time lag between a patent application being published and it being granted, which can be (and often is) several years. Bearing this in mind, a rough indication of how well Chinese applicants are currently doing can be got from counting the number of granted European applications based on their country of origin. This is shown in the chart below, which compares the number of granted EPs originating from China and the US (the data for this was obtained from the EPO's annual statistics pages). The obvious large increase in grant rate for 2016 has been noted by the EPO here, together with a (possibly dubious) claim that quality has not been compromised. What is fairly obvious from this is that China is a long way behind the US in terms of granted patents, at the EPO at least. It would clearly take quite a few more years before China reaches the levels that the US has been consistently seeing for more than ten years.
The USPTO also provide some statistics detailing the number of patents granted, breaking these down into country of origin. The data for the years 2004 to 2015 (2016 is not yet available) is shown below. The numbers are much larger than those for the EPO, but the story is roughly the same. China is still a long way behind in terms of the number of patents granted, and there are no signs yet of China approaching comparable levels for the foreseeable future.
In conclusion, claims about the Chinese becoming increasingly important in terms of patent applications do seem to be correct, and we may well see China becoming a dominant player in international applications in the near future. As far as granted patents are concerned, however, China seems to be far behind the established players and it is unclear at the moment whether this is likely to change in a big way any time soon. As for the causes of this discrepancy, my guess is that the incentives to file applications in China are probably having a big effect on the application figures, and many applications are being filed without much thought being given as to whether they might result in a granted patent. Some of these applications will inevitably be patentable, but I suspect the proportion, at least at the moment, is still quite low.
Any idea of the average pendancy time at the EPO/USPTO to grant/refusal?
ReplyDeleteAs you say, there is a time lag, but without some info on the average time an application is pending, it is difficult to work out whether the relatively poor showing in rate of grant for Chinese originating applications is purely down to time delay, or whether (for whatever reason) the conversion rate of PCT->granted EP/US is lower.
One indicator would be to look at the proportion of EP regional phase entries from CN compared to the US. For PCT applications filed in 2015, there were 25,487 from China and 55,062 from the US. According to the EPO, in 2016 there were 7,150 EP applications originating from China (although this includes direct EP filings as well as regional phase entries), compared to 40,726 from the US. This indicates a much higher conversion rate from the US compared to China, which fits with the hypothesis that filing PCT applications is being encouraged in China, but these are not being following through as much.
DeleteAs to motives for drafting and filing patent applications, there are many, and I think you can see them shift steadily and progressively, as you track east from San Francisco to Tokyo, passing through Europe on the way. Filers in Asia are not motivated by the quantum of damages awarded when sellers of successful products are deemed to have infringed wilfully. Instead they are motivated by more defensive considerations, such as:
ReplyDelete...fulfilling the terms of their Employee Inventor Law (which obliges them to file)
...using the A publications to "keep clear" their technological path ahead
...boosting their share price, as gullible investors suppose that more filings equals more future profits
...having "something to trade", Trump-like, when they get sued in an English law jurisdiction.
When China gets to parity with the west, in high technology, shall we recognise that from China's patent filings? I'm not sure. I imagine they will keep their Crown Jewels to themselves.
Meanwhile, all those WO publications are a potent source of prior art under the AIA because you can rely on them for obviousness attacks, not just from their date of publication as under the EPC, but rather, all the way back to their priority date in China. The Americans didn't just switch over to First to File. No, they had to go one better, so chose First to File but with world-wide "54(39" unpublished prior filings anywhere in the world available for obviousness attacks, regardless whether it has entered the USA national phase.
No wonder there are a lot of WO publications by Applicants from China.